Immunity to varicella zoster virus in young Israeli adults

Chickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and self-limiting disease in otherwise healthy children, chickenpox can be a complicated and even life-threatening disease in adults, pregnant women and immunosuppres...

Full description

Saved in:
Bibliographic Details
Published in:The Israel Medical Association journal Vol. 2; no. 3; pp. 196 - 199
Main Authors: Avrahami-Heller, Y, Cohen, D, Orr, N, Slepon, R, Ashkenazi, I, Danon, Y L
Format: Journal Article
Language:English
Published: Israel 01-03-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Chickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and self-limiting disease in otherwise healthy children, chickenpox can be a complicated and even life-threatening disease in adults, pregnant women and immunosuppressed individuals. Among infants whose mothers had varicella during the first trimester of pregnancy, 2-3% will develop a congenital VZV syndrome that includes a combination of scarring, limb deformation, central nervous system impairment and ocular injury. In 1974, a live attenuated virus vaccine against VZV was developed in Japan and has been thoroughly tested for safety, efficacy and long-term effects. In March 1995 the vaccine was licensed in the U.S. for use in healthy children only. To determine the rate of immunity to VZV in young Israeli adults. On the assumption that a randomly picked sample of 18-year-old army recruits in Israel is representative of the general Jewish population, 900 sera samples were taken for 3 years (1985,1988,1992). The sera were analyzed for IgG to VZV with a commercial ELISA kit using microwells coated with VZV antigens. A total of 98% of the samples tested positive for VZV antibodies. The difference in serologic values between the recruitment years was not statistically significant. The majority of the Israeli population reaches adulthood already immunized against VZV, with immigrants having slightly lower immunity rates. Nonetheless, a few dozen cases of chickenpox are diagnosed in the IDF annually. These data should be taken into account when a vaccination program is devised. Should such a program be implemented, it would be interesting to repeat the serosurvey for comparison. A shift in the peak occurrence age might necessitate the administration of a booster vaccine at an older age.
AbstractList Chickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and self-limiting disease in otherwise healthy children, chickenpox can be a complicated and even life-threatening disease in adults, pregnant women and immunosuppressed individuals. Among infants whose mothers had varicella during the first trimester of pregnancy, 2-3% will develop a congenital VZV syndrome that includes a combination of scarring, limb deformation, central nervous system impairment and ocular injury. In 1974, a live attenuated virus vaccine against VZV was developed in Japan and has been thoroughly tested for safety, efficacy and long-term effects. In March 1995 the vaccine was licensed in the U.S. for use in healthy children only. To determine the rate of immunity to VZV in young Israeli adults. On the assumption that a randomly picked sample of 18-year-old army recruits in Israel is representative of the general Jewish population, 900 sera samples were taken for 3 years (1985,1988,1992). The sera were analyzed for IgG to VZV with a commercial ELISA kit using microwells coated with VZV antigens. A total of 98% of the samples tested positive for VZV antibodies. The difference in serologic values between the recruitment years was not statistically significant. The majority of the Israeli population reaches adulthood already immunized against VZV, with immigrants having slightly lower immunity rates. Nonetheless, a few dozen cases of chickenpox are diagnosed in the IDF annually. These data should be taken into account when a vaccination program is devised. Should such a program be implemented, it would be interesting to repeat the serosurvey for comparison. A shift in the peak occurrence age might necessitate the administration of a booster vaccine at an older age.
BACKGROUNDChickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and self-limiting disease in otherwise healthy children, chickenpox can be a complicated and even life-threatening disease in adults, pregnant women and immunosuppressed individuals. Among infants whose mothers had varicella during the first trimester of pregnancy, 2-3% will develop a congenital VZV syndrome that includes a combination of scarring, limb deformation, central nervous system impairment and ocular injury. In 1974, a live attenuated virus vaccine against VZV was developed in Japan and has been thoroughly tested for safety, efficacy and long-term effects. In March 1995 the vaccine was licensed in the U.S. for use in healthy children only.OBJECTIVESTo determine the rate of immunity to VZV in young Israeli adults.METHODSOn the assumption that a randomly picked sample of 18-year-old army recruits in Israel is representative of the general Jewish population, 900 sera samples were taken for 3 years (1985,1988,1992). The sera were analyzed for IgG to VZV with a commercial ELISA kit using microwells coated with VZV antigens.RESULTSA total of 98% of the samples tested positive for VZV antibodies. The difference in serologic values between the recruitment years was not statistically significant.CONCLUSIONThe majority of the Israeli population reaches adulthood already immunized against VZV, with immigrants having slightly lower immunity rates. Nonetheless, a few dozen cases of chickenpox are diagnosed in the IDF annually. These data should be taken into account when a vaccination program is devised. Should such a program be implemented, it would be interesting to repeat the serosurvey for comparison. A shift in the peak occurrence age might necessitate the administration of a booster vaccine at an older age.
Author Orr, N
Avrahami-Heller, Y
Slepon, R
Ashkenazi, I
Cohen, D
Danon, Y L
Author_xml – sequence: 1
  givenname: Y
  surname: Avrahami-Heller
  fullname: Avrahami-Heller, Y
  organization: Kipper Institute of Immunology, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel
– sequence: 2
  givenname: D
  surname: Cohen
  fullname: Cohen, D
– sequence: 3
  givenname: N
  surname: Orr
  fullname: Orr, N
– sequence: 4
  givenname: R
  surname: Slepon
  fullname: Slepon, R
– sequence: 5
  givenname: I
  surname: Ashkenazi
  fullname: Ashkenazi, I
– sequence: 6
  givenname: Y L
  surname: Danon
  fullname: Danon, Y L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/10774265$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKxDAYRrMYcS76CpKVu0KSNk3iTgYvhQE3M-uStn8k0iY1l4H69IqOq7M5HL5vi1bOO1ihDeU1LyiRco22MX4Qwjgn6hqtKRGiYjXfoIdmmrKzacHJ47MOtodx1PjLxwQBn23IEVuHF5_dO25i0DBarIc8pniDroweI9xeuEOn56fj_rU4vL00-8dDMTMiUmE0SCUUB5BlR7iWXNZKGSmk6Q1opkvWmUFRPZBOUFNzqMp-AMMk6xVTXblD93_dOfjPDDG1k42_Mx34HFtBSSV5RX_Eu4uYuwmGdg520mFp_9-W3-VmUkk
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 199
ExternalDocumentID 10774265
Genre Journal Article
GeographicLocations Israel
GeographicLocations_xml – name: Israel
GroupedDBID ---
2WC
53G
5GY
9LF
ADBBV
AEGXH
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CUY
CVF
DIK
E3Z
EBD
EBS
ECM
EIF
EJD
EMOBN
EOJEC
F5P
FRP
GX1
MK0
NPM
OBODZ
OK1
SV3
TR2
W2D
XSB
ZXP
7X8
ID FETCH-LOGICAL-p207t-fae89795ee83b05a858699f878fcfea2a32bfd91ad0b71f65e43cdef282c929b3
ISSN 1565-1088
IngestDate Thu Apr 11 20:14:59 EDT 2024
Thu May 23 23:04:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p207t-fae89795ee83b05a858699f878fcfea2a32bfd91ad0b71f65e43cdef282c929b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 10774265
PQID 71048541
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_71048541
pubmed_primary_10774265
PublicationCentury 2000
PublicationDate 2000-03-01
PublicationDateYYYYMMDD 2000-03-01
PublicationDate_xml – month: 03
  year: 2000
  text: 2000-03-01
  day: 01
PublicationDecade 2000
PublicationPlace Israel
PublicationPlace_xml – name: Israel
PublicationTitle The Israel Medical Association journal
PublicationTitleAlternate Isr Med Assoc J
PublicationYear 2000
References 10774272 - Isr Med Assoc J. 2000 Mar;2(3):224
References_xml
SSID ssj0025509
Score 1.6095743
Snippet Chickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and self-limiting disease...
BACKGROUNDChickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 196
SubjectTerms Adolescent
Adult
Antibodies, Viral - blood
Emigration and Immigration
Enzyme-Linked Immunosorbent Assay
Female
Herpesvirus 3, Human - immunology
Humans
Immunity
Immunoglobulin G - blood
Israel
Male
Military Personnel
Title Immunity to varicella zoster virus in young Israeli adults
URI https://www.ncbi.nlm.nih.gov/pubmed/10774265
https://search.proquest.com/docview/71048541
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ05a8MwFMdF06F0Kb3vVkO3YPAhWXK30iQk9MjQBLIZ2ZYgUJzgHNB--j7JZ4bSduhijIwP9JPl_5PfgdAdUQq-cpRYMg4UGCgRtzi1PQuUa8x4IiIq9Jpu_429TninS7p1vby67V9JQxuw1pGzf6BdXRQaYB-Ywxaow_ZX3Acm4GNpROVa6JRBALr9qWM5svZ6mq2MA-yHfsnbg0Um5Ps0T8KxaOpUU3zeHK1-5TRAtptPokfL2sRbT62-LCMLK4VcxX9UrsXDLNv8B_QORkBaOy-WaxB27YRVTpu-zmeaF-gr51W3MXy8xhzpBH7jc-vk9ZE2M2G_DsPe-Pk5HHUnoxZqeY521uwMnipTGuyqwGTCLe77vX1gdMJoH-0VAh8_5GQO0JZMD9HOS-HCcITuS0B4OcMVIJwDwgYQnqbYAMIFIJwDOkbjXnf02LeKAhbW3LXZ0lJC8oAFVEruRTYVnHI_CBRnXMVKCld4bqSSwBGJHTFH-VQSL06kAjM4BtkaeSdoO52l8gzhxNb5o1wiGI-IBKvX12HDjIOCjojwvXN0W3ZACBOEefRUzlaLECQk4ZQ45-g075dwnucxCcHyZyDQ6MWP516i3Rr7FdpeZit5jVqLZHVjuHwBDVU8Eg
link.rule.ids 315,782,786
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunity+to+varicella+zoster+virus+in+young+Israeli+adults&rft.jtitle=The+Israel+Medical+Association+journal&rft.au=Avrahami-Heller%2C+Y&rft.au=Cohen%2C+D&rft.au=Orr%2C+N&rft.au=Slepon%2C+R&rft.date=2000-03-01&rft.issn=1565-1088&rft.volume=2&rft.issue=3&rft.spage=196&rft.epage=199&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1565-1088&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1565-1088&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1565-1088&client=summon